A parathyroidectomy is the surgical removal of one or more parathyroid glands, four tiny glands in the neck that control calcium levels in your blood. The operation is most commonly performed to treat hyperparathyroidism, a condition where one or more of these glands become overactive and pump out too much parathyroid hormone, driving calcium levels dangerously high. With cure rates between 95% and 99% at experienced centers, it is one of the most reliably successful operations in endocrine surgery.
Why the Parathyroid Glands Matter
Your parathyroid glands sit behind the thyroid gland in your neck, roughly the size of a grain of rice each. Despite their small size, they play an outsized role: they produce parathyroid hormone (PTH), which tells your bones to release calcium into the bloodstream, your kidneys to hold onto calcium, and your gut to absorb more of it from food. When one gland develops a benign tumor called an adenoma, it can churn out PTH nonstop, pulling calcium from your bones whether your body needs it or not.
The result is primary hyperparathyroidism. Over time, elevated calcium weakens bones, forms kidney stones, and can cause fatigue, brain fog, depression, muscle weakness, and frequent urination. Some people have obvious symptoms; others discover the problem through routine blood work showing high calcium levels. In both cases, surgery is the only cure.
Who Needs the Surgery
If you have symptoms like kidney stones or significant bone loss, the case for surgery is straightforward. The decision gets more nuanced when hyperparathyroidism shows up on lab work but hasn’t caused noticeable problems yet. International guidelines recommend surgery for asymptomatic patients who meet any of these criteria:
- Calcium level more than 1.0 mg/dL above the upper limit of normal
- Bone density T-score of -2.5 or lower at the spine, hip, or forearm, or any vertebral fracture found on imaging
- Kidney function below a creatinine clearance of 60 mL/min, or evidence of kidney stones or calcium deposits in the kidneys
- Age younger than 50, since decades of elevated calcium pose a greater cumulative risk
The age-50 threshold has stayed consistent across multiple guideline updates, even as life expectancy has risen. Some researchers have argued it should be revisited for older patients who are otherwise healthy and might benefit from surgery regardless of age.
Finding the Problem Gland Before Surgery
Most cases of primary hyperparathyroidism involve a single overactive gland, so pinpointing its location before the operation allows a smaller, more targeted surgery. Surgeons typically rely on a combination of imaging techniques to map the gland’s position.
Ultrasound is usually the first step because it’s quick and radiation-free, but its sensitivity is moderate. A sestamibi scan, which uses a small amount of radioactive tracer that overactive parathyroid tissue absorbs more readily, adds another layer of information. The most accurate option is a specialized CT scan called 4D-CT, which correctly identifies the side of the diseased gland about 77% of the time, compared to roughly 46% for sestamibi and 39% for ultrasound. When imaging results agree, surgeons can plan a focused approach with confidence.
Localization becomes especially important because parathyroid glands don’t always sit where they’re supposed to. During fetal development, these glands migrate down from the jaw area into the neck, and sometimes they end up in unusual spots: inside the thymus gland in the chest, embedded within the thyroid itself, tucked behind the esophagus, or deep in the mediastinum (the central compartment of the chest). These ectopic glands account for many cases where a first surgery fails to find the culprit.
How the Surgery Works
There are two main approaches. The traditional method, called bilateral neck exploration, involves opening both sides of the neck so the surgeon can visually inspect all four parathyroid glands and remove whichever ones are enlarged. This was the standard for decades and remains necessary when more than one gland is diseased or when imaging can’t pinpoint the problem.
The newer approach, minimally invasive parathyroidectomy, uses preoperative imaging to target just the one abnormal gland through a smaller incision on one side of the neck. It takes about 18 minutes less than bilateral exploration on average and generally means less tissue disruption, less pain, and a quicker return to normal activity. Most patients with a clearly localized single adenoma are candidates for this approach.
During either procedure, many surgeons draw blood samples in the operating room to measure PTH levels in real time. Because PTH breaks down quickly in the bloodstream (its half-life is only a few minutes), a drop of at least 50% from the highest pre-removal level within 10 minutes of excising the gland confirms the overactive tissue has been successfully removed. This intraoperative monitoring reduces the chance of leaving behind additional diseased tissue and often allows the surgeon to close the incision with greater confidence.
Risks and Complications
Parathyroidectomy is considered a low-risk operation, but no surgery is risk-free. The two concerns specific to this procedure are nerve injury and low calcium afterward.
The recurrent laryngeal nerve runs very close to the parathyroid glands and controls the vocal cords. Temporary hoarseness or voice changes affect a small percentage of patients and typically resolve within weeks. Permanent nerve damage is rare, occurring in roughly 1% to 2% of cases.
Transient low calcium (hypocalcemia) is the most common post-operative issue. Your remaining parathyroid glands may take a few days to “wake up” after the overactive one is removed, and during that gap your calcium can dip. Symptoms include tingling in the fingertips or around the lips, muscle cramps, and in more pronounced cases, spasms. Most patients manage this with calcium and vitamin D supplements in the short term, and levels normalize as the remaining glands adjust.
Hungry Bone Syndrome
In patients who had significantly elevated PTH for a long time, the bones may have been losing calcium for months or years. Once the excess PTH is gone, the skeleton rapidly starts pulling calcium back in to rebuild, like a sponge soaking up water. This phenomenon, called hungry bone syndrome, causes calcium levels to drop below 8.4 mg/dL and stay low for more than four days after surgery. Phosphate and magnesium levels often fall too.
Patients with very high PTH levels before surgery and those whose calcium was already on the lower side are most at risk. During the first week after surgery, calcium requirements can be substantial, averaging around 3.2 grams of elemental calcium per day in some patients, tapering to about 2.4 grams by the sixth week. Your surgical team will monitor your levels closely and adjust your supplements accordingly. Hungry bone syndrome is temporary, but it can take weeks to months for mineral levels to fully stabilize.
Recovery and What to Expect
Most patients go home the same day or the day after surgery, particularly with the minimally invasive approach. The incision is typically small and heals in the natural skin creases of the neck, making the eventual scar difficult to notice. Neck soreness, mild swelling, and a scratchy throat from the breathing tube during anesthesia are common for the first few days.
Many people notice improvements quickly. The mental fog, fatigue, and low mood that often accompany hyperparathyroidism can begin lifting within days to weeks, though bone density improvements take longer, often a year or more. Kidney stone risk drops significantly once calcium levels normalize.
You’ll have follow-up blood work to confirm that calcium and PTH levels have returned to the normal range. In the large majority of patients, a single operation is all that’s needed. One study of over 350 patients found a first-operation cure rate of 96%, with an overall cure rate of nearly 98% when reoperations were included. Recurrence is uncommon, developing in about 1% of patients during long-term follow-up. Persistent or recurrent disease, once seen in up to 30% of cases in the 1990s, now occurs in only 2.5% to 5% of patients thanks to better imaging and intraoperative monitoring.